Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Suppliers See Ingredient Branding As Key To Greater Market Presence

This article was originally published in The Tan Sheet

Executive Summary

Supply firms are focusing on branding their ingredients as they pursue category leadership within the dietary supplement industry

You may also be interested in...



Xangold Lutein Qualified Health Claim Sought By Cognis

Cognis Nutrition & Health is petitioning FDA for a qualified health claim linking its Xangold Natural Lutein Esters to a reduced risk of age-related macular degeneration (AMD) and cataracts

Phytosterol CHD Health Claim Expanded Interim Use Permitted By FDA

FDA will allow the use of a phytosterol heart health claim on a broader range of foods, beverages and dietary supplements while it completes a final rule on the issue, according to a Feb. 14 open letter posted on the agency's Web site

Osteoarthritis study

Spanish firm BioIberica will supply chondroitin sulfate for the NIH-funded study on osteoarthritis, an NIH steering committee decides Sept. 28. Pfanstiehl Labs is providing the glucosamine. The trial, co-sponsored by NCCAM and NIAMS, was slated to start several months ago but was stalled due to difficulty in choosing supplement suppliers (1"The Tan Sheet" Sept. 4, p. 4). Enrollment is expected to begin in late October

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098878

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel